Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone

Clinical trial NCT06060587 · WITHDRAWN

Trial details

NCT number: NCT06060587
Sponsor: Northwestern University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-10-19
Primary completion: 2024-05-03
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.